Enterprise Financial Services Corp Bio Techne Corp Transaction History

Enterprise Financial Services Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $27,581 - $33,410	-62 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$314.62 - $411.0 $629 - $822	2 Added 3.33%	62 $24,000
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $4,197 - $5,471	17 Added 39.53%	60 $19,000
Q2 2020 Aug 04, 2020	BUY	$185.43 - $279.56 $1,112 - $1,677	6 Added 16.22%	43 $11,000
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $1,289 - $1,772	8 Added 27.59%	37 $7,000
Q3 2017 Oct 27, 2017	BUY	$113.59 - $123.78 $3,294 - $3,589	29	29 $4,000

619

156M

161K

12.7K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.4B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.